Outset MedicalOM

13F holders, Q2 2025 (June 30)
2holders
1new positions
1sold out
$19.23avg. 13F price*

At the end of Q2 2025, 2 institutions reported holding Outset Medical Inc. (OM) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were Birchview Capital, LP ($664K) and Accent Capital Management, LLC ($4K).

Company
Outset Medical Inc.
Filed as
OUSTER INC A (Q2 2025)
CUSIP
690145107
Latest filing quarter
Q1 2026

History

Number of 13F holders

050100150 Q1 2024: 114Q1 2024Q2 2024: 122Q2 2024Q3 2024: 80Q3 2024Q4 2024: 74Q4 2024Q1 2025: 2Q1 2025Q2 2025: 2Q2 2025Q3 2025: 3Q3 2025Q4 2025: 3Q4 2025Q1 2026: 2Q1 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions1$4K
Exits1$9

All 13F filers, Q1 2025 → Q2 2025: 10,150 shares bought and 16 shares sold, net +10,134 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Birchview Capital, LP 0.66% Add +40.7% 34,584 $664K
Accent Capital Management, LLC 0.00% New 150 $4K

"% of holder's portfolio" is OM's weight in each manager's 13F, not the share of Outset Medical Inc. the manager owns.